參考文獻 |
1.Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet. 2004 Aug 14-20; 364(9434): 613-20.
2.Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006 Sep; 28(3): 523-32.
3.Villeneuve S, Pepin V, Rahayel S, et al. Mild cognitive impairment in moderate to severe COPD: a preliminary study. Chest. 2012 Dec; 142(6): 1516-23.
4.Crişan AF, Oancea C, Timar B, Fira-Mladinescu O, Crişan A, Tudorache V. Cognitive impairment in chronic obstructive pulmonary disease. PLoS One. 2014 Jul 17; 9(7).
5.Kumar Amit, Vandana. REVIEW ARTICLE DEMENTIA: AN OVERVIEW. Journal of Drug Delivery & Therapeutics; 2013, 3(3), 163-167.
6.Boeve BF. A review of the non-Alzheimer dementias. J Clin Psychiatry. 2006 Dec; 67(12): 1985-2001.
7.Busse A, Angermeyer MC, Riedel-Heller SG. Progression of mild cognitive impairment to dementia: a challenge to current thinking. Br J Psychiatry. 2006 Nov; 189: 399-404.
8.Gerhard W Eschweiler, Thomas Leyhe, Stefan Klöppel, Michael Hüll. New Developments in the Diagnosis of Dementia Dtsch Arztebl Int. Oct 2010; 107(39): 677–683.
9.Singh B, Mielke MM, Parsaik AK, et al. A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment. JAMA Neurol. 2014 May; 71(5): 581-8.
10.Antonelli-Incalzi R, Corsonello A, Pedone C, Trojano L, Acanfora D, Spada A, Izzo O, Rengo F. Drawing impairment predicts mortality in severe COPD. Chest. 2006 Dec; 130(6): 1687-94.
11.Dodd JW1, Getov SV, Jones PW. Cognitive function in COPD. Eur Respir J. 2010 Apr; 35(4): 913-22.
12.Schou L, Østergaard B, Rasmussen LS, Rydahl-Hansen S, Phanareth K. Cognitive dysfunction in patients with chronic obstructive pulmonary disease--a systematic review. Respir Med. 2012 Aug; 106(8): 1071-81.
13.Singh B, Parsaik AK, Mielke MM, et al. Chronic obstructive pulmonary disease and association with mild cognitive impairment: the Mayo Clinic Study of Aging. Mayo Clin Proc. 2013 Nov; 88(11): 1222-30.
14.Rusanen M, Ngandu T, Laatikainen T, Tuomilehto J, Soininen H, Kivipelto M. Chronic obstructive pulmonary disease and asthma and the risk of mild cognitive impairment and dementia: a population based CAIDE study. Curr Alzheimer Res. 2013 Jun; 10(5): 549-55.
15.W.-C. Liao, C.-L. Lin, S.-N. Chang, C.-Y. Tu and C.-H. Kao. The association between chronic obstructive pulmonary disease and dementia: a population-based retrospective cohort study. European Journal of Neurology 2014, 0: 1–7
16.Rabe KF, Hurd S, Anzueto A, el al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007 Sep 15; 176(6): 532-55.
17.Li J, Huang Y, Fei GH. The evaluation of cognitive impairment and relevant factors in patients with chronic obstructive pulmonary disease. Respiration. 2013; 85(2): 98-105.
18.National Health Insurance Database: LHID Backgroud; 2014. http://nhird.nhri.org.tw/en/.
19.Corrada MM, Brookmeyer R, Paganini-Hill A, Berlau D, Kawas CH. Dementia incidence continues to increase with age in the oldest old: the 90+ study. Ann Neurol. 2010 Jan; 67(1):114-21.
20.Xu WL, Atti AR, Gatz M, Pedersen NL, Johansson B, Fratiglioni L. Midlife overweight and obesity increase late-life dementia risk: a population-based twin study. Neurology. 2011 May 3; 76(18): 1568-74.
21.Tzung-Yi Tsai, Hanoch Livneh, Ming-Chi Lu, et al. Increased risk and related factors of depression among patients with COPD: a population-based cohort study. BMC Public Health 2013, 13: 976
22.Wang MT, Tsai CL, Lo YW, Liou JT, Lee WJ, Lai IC. Risk of stroke associated with inhaled ipratropium bromide in chronic obstructive pulmonary disease: a population-based nested case-control study. Int J Cardiol. 2012 Jul 12; 158(2):279-84.
23.Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993 Oct; 46(10): 1075-9.
24.Cramer C, Haan MN, Galea S, Langa KM, Kalbfleisch JD. Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study. Neurology. 2008 Jul 29; 71(5): 344-50.
25.Jonker C, Comijs HC, Smit JH. Does aspirin or other NSAIDs reduce the risk of cognitive decline in elderly persons? Results from a population-based study. Neurobiol Aging. 2003 Jul-Aug; 24(4): 583-8.
26.Hsu C-C, Wahlqvist ML, Lee M-S, Tsai H-N. Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin. Journal of Alzheimer′s disease. 02/2011; 24(3): 485-93.
27.Johnson ML, Parikh N, Kunik ME, et al. Antihypertensive drug use and the risk of dementia in patients with diabetes mellitus. Alzheimers Dement. 2012 Sep; 8(5): 437-44.
28.Sara C Hitchman,Geoffrey T Fong Gender empowerment and female-to-male smoking prevalence ratios. Bulletin of the World Health Organization 2011; 89: 195-202.
29.Schmidt R, Schmidt H, Curb JD, Masaki K, White LR, Launer LJ. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol. 2002 Aug; 52(2): 168-74.
30.Engelhart MJ, Geerlings MI, Meijer J, et al. Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Arch Neurol. 2004 May; 61(5): 668-72.
31.Kalaria RN, Maestre GE, Arizaga R, et al. Alzheimer′s disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol. 2008 Sep; 7(9): 812-26.
32.Wysocki M1, Luo X, Schmeidler J, Dahlman K, et al. Hypertension is associated with cognitive decline in elderly people at high risk for dementia. Am J Geriatr Psychiatry. 2012 Feb; 20(2): 179-87.
33.Modrego PJ, Ferrández J. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study. Arch Neurol. 2004 Aug; 61(8): 1290-3.
34.Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009 Nov; 8(11): 1006-18.
35.Qiu C, Winblad B, Marengoni A, Klarin I, Fastbom J, Fratiglioni L. Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study. Arch Intern Med. 2006 May 8; 166(9): 1003-8.
36.Chang KH1, Chung CJ, Lin CL, Sung FC, Wu TN, Kao CH. Increased risk of dementia in patients with osteoporosis: a population-based retrospective cohort analysis. Age (Dordr). 2014 Apr; 36(2): 967-75.
37.Xu WL, von Strauss E, Qiu CX, Winblad B, Fratiglioni L. Uncontrolled diabetes increases the risk of Alzheimer′s disease: a population-based cohort study. Diabetologia. 2009 Jun; 52(6): 1031-9.
38.Pearce JM. Brain disease leading to mental illness: a concept initiated by the discovery of general paralysis of the insane. Eur Neurol. 2012; 67(5): 272-8.
|